Trajectories of sentiment in 11,816 psychoactive narratives
Sam Friedman, Galen Ballentine
Human Psychopharmacology: Clinical and Experimental December 20, 2023 DOI: 10.1002/hup.2889 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study using machine learning and natural language processing Peer reviewed |
|---|---|
| Sample size | 11,816 |
| Population | Publicly available testimonials about 52 different psychoactive drugs |
| Keywords | Narrative Surprise Parallels Cognitive psychology |
| Citations | 5 |
| Key findings | Machine learning can quantify subjective drug experiences, revealing a distinction between psychedelic heights and the experiences of addiction and mental illness, with specific drugs linked to distinct sentiment dimensions. |
Abstract
Abstract Objective Can machine learning (ML) enable data‐driven discovery of how changes in sentiment correlate with different psychoactive experiences? We investigate by training models directly on text testimonials from a diverse 52‐drug pharmacopeia.
Methods: Using large language models (i.e. BERT) and 11,816 publicly‐available testimonials, we predicted 28‐dimensions of sentiment across each narrative, and then validated these predictions with adjudication by a clinical psychiatrist. BERT was then fine‐tuned to predict biochemical and demographic information from these narratives. Lastly, canonical correlation analysis linked the drugs' receptor affinities with word usage, revealing 11 statistically‐significant latent receptor‐experience factors, each mapped to a 3D cortical Atlas.
Results: These methods elucidate a neurobiologically‐informed, sequence‐sensitive portrait of drug‐induced subjective experiences. The models' results converged, revealing a pervasive distinction between the universal psychedelic heights of feeling in contrast to the grim, mundane, and personal experiences of addiction and mental illness. Notably, MDMA was linked to “Love”, DMT and 5‐MeO‐DMT to “Mystical Experiences” and “Entities and Beings”, and other tryptamines to “Surprise”, “Curiosity” and “Realization".
Conclusions: ML methods can create unified and robust quantifications of subjective experiences with many different psychoactive substances and timescales. The representations learned are evocative and mutually confirmatory, indicating great potential for ML in characterizing psychoactivity.
Citations in the library
Cites 13
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV) PLoS One August 31, 2010
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin Journal of Psychopharmacology October 6, 2015
- The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacology & Translational Science December 10, 2020
- Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study Psychopharmacology March 1, 2004
and 8 more in the library